ภาควิชากุมารเวชศาสตร์ | คณะแพทยศาสตร์ศิริราชพยาบาล มหาวิทยาลัยมหิดล

1.

Chiaprasert P.; Lolekha R.; Rungmaitree S.; Maleesatharn A.; Sethaputra C.; Durier Y.; Srisoonthonthai P.; Pumpradit W.; Northbrook S.C.; Weerarak P.; Chokephaibulkit K.

Outreach strategies to promote HIV testing and linkage-to-care focusing on a young sexual and gender-diverse population in Bangkok, Thailand
PLoS ONE. 2024. 19 (1):

2.

Rungmaitree S, Werarak P, Pumpradit W, Phongsamart W, Lapphra K, Wittawatmongkol O, Durier Y, Maleesatharn A, Kuttiparambil B, Cressey TR, Hoffman RM, Chokephaibulkit K.

A pilot program of HIV pre-exposure prophylaxis in Thai youth
PLoS One. 2024. 19 (2):

3.

Ounchanum P, Aurpibul L, Teeraananchai S, Lumbiganon P, Songtaweesin WN, Sudjaritruk T, Chokephaibulkit K, Rungmaitree S, Kosalaraksa P, Suwanlerk T, Ross JL, Sohn AH, Puthanakit T.

High mortality in adolescents and young adults with perinatally-acquired HIV in Thailand during the transition to adulthood
AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. 2024. 1-10.

4.

Rodriguez C.A.; Natukunda E.; Strehlau R.; Venter E.L.; Rungmaitree S.; Cunningham C.K.; Lalloo U.; Kosalaraksa P.; HellstrÖm E.; Liberty A.; McGrath E.J.; Kaur M.; Leisegang R.; Hindman J.T.; Vieira V.A.; Kersey K.; Cotton M.F.; Rakhmanina N.; Gaur A.H.

Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study
Lancet HIV. 2024. 11 (5): e300-e308.

5.

Santiprabhob J.; Chokephaibulkit K.; Khantee P.; Maleesatharn A.; Phonrat B.; Phongsamart W.; Lapphra K.; Wittawatmongkol O.; Rungmaitree S.; Tanchaweng S.; Maturapat S.; Lermankul W.; Tungtrongchitr R.

Corrigendum to “Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors” [Cytokine 136 (2020) 155145] (Cytokine (2020) 136, (10.1016/j.cyto.2020.155145))
Cytokine. 2024. 180

6.

Zaniewski E, Skrivankova VW, Brazier E, Avihingsanon A, Cardoso SW, Cesar C, Chenal H, Crabtree-Ramírez BE, Ditangco RA, Ebasone PV, Eley B, Euvrard JG, Fatti G, Huwa JM, Lelo P, Machado DM, Messou EK, Minga AK, Muleebwa J, Mundhe S, Murenzi G, Muyindike WR, Nsonde DM, Obatsa SM, Odhiambo J, Prozesky HW, Rungmaitree S, Semeere AS, Seydi M, Sipambo N, Sudjaritruk T, Technau KG, Tiendrebeogo T, Twizere C, Ballif M.

Transition to dolutegravir-based ART in 35 low- and middle-income countries: a global survey of HIV care clinics
AIDS. 2024.

7.

Aurpibul L., Kosalaraksa P., Kawichai S., Lumbiganon P., Ounchanum P., Natalie Songtaweesin W., Sudjaritruk T., Chokephaibulkit K., Rungmaitree S., Suwanlerk T., Ross J.L., Sohn A.H., Puthanakit T., Thai PAPAYA study team

Alcohol use, suicidality and virologic non-suppression among young adults with perinatally acquired HIV in Thailand: a cross-sectional study
Journal of the International AIDS Society. 2023. 26 (2):

8.

Chokephaibulkit K, Puthanakit T, Chaithongwongwatthana S, Bhat N, Tang Y, Anugulruengkitt S, Chayachinda C, Anuwutnavin S, Lapphra K, Rungmaitree S, Tawan M, Andi-Lolo I, Holt R, Fortuna L, Kerdsomboon C, Yuwaree V, Mansouri S, Thai PH, Innis BL.

A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women
Vaccine. 2023.

9.

Chinula L.; Ziemba L.; Brummel S.; McCarthy K.; Coletti A.; Krotje C.; Johnston B.; Knowles K.; Moyo S.; Stranix-Chibanda L.; Hoffman R.; Sax P.E.; Stringer J.; Chakhtoura N.; Jean-Philippe P.; Korutaro V.; Chalermchockcharoenkit A.; Thamkhantho M.; Werarak P.; Rungmaitree S.; Achalapong J.; Sitiritkawin L.

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
The Lancet HIV. 2023. 10 (6): e363-e374.

10.

Sanchez L, Rungmaitree S, Kosalaraksa P, Jantarabenjakul W, Leclercq J, Yaiprayoon Y, Midde VJ, Varghese K, Mangarule S, Noriega F.

Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand
Pediatr Infect Dis J. 2023.

ผลงานที่ได้รับการตีพิมพ์

ผศ.พญ. สุพัตรา รุ่งไมตรี